Br J Cancer. 2002 Feb 1;86(3):402-8.
Cyclin A is a prognostic indicator in early stage breast cancer with and
without tamoxifen treatment.
Michalides R, van Tinteren H, Balkenende A, Vermorken JB, Benraadt J, Huldij J, van Diest P,
Division of Tumour Biology, the Netherlands Cancer Institute, Plesmanlaan
121, 1066 CX Amsterdam, The Netherlands. rmichal@nki.nl
Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1394-404.
Quality of life as a survival predictor for esophageal squamous cell
carcinoma treated with radiotherapy.
Fang FM, Tsai WL, Chiu HC, Kuo WR, Hsiung CY,
Department of Radiation Oncology, Kaohsiung Chang Gung Memorial Hospital,
Kaohsiung Hsien, Taiwan. a7323630@ms14.hinet.net
Psychol Assess. 2004 Sep;16(3):255-66.
Construct validity of the posttraumatic stress disorder checklist in
cancer survivors: analyses based on two samples.
DuHamel KN, Ostrof J, Ashman T, Winkel G, Mundy EA, Keane TM, Morasco BJ, Vickberg SM, Hurley K, Burkhalter J, Chhabra R, Scigliano E, Papadopoulos E, Moskowitz C, Redd W,
Program for Cancer Prevention and Control, Department of Oncological
Sciences, Mount Sinai School of Medicine, New York, NY 10029, USA.
duhamel@mssm.edu
J Clin Oncol. 2005 Jan 1;23(1):175-83.
Clinical model to predict survival in chemonaive patients with advanced
non-small-cell lung cancer treated with third-generation chemotherapy
regimens based on eastern cooperative oncology group data.
Hoang T, Xu R, Schiller JH, Bonomi P, Johnson DH,
University of Wisconsin Medical School, 600 Highland Ave, K4/562, Madison,
WI, USA. txh@medicine.wisc.edu
J Urol. 2005 May;173(5):1496-501.
Using tumor markers to predict the survival of patients with metastatic
renal cell carcinoma.
Kim HL, Seligson D, Liu X, Janzen N, Bui MH, Yu H, Shi T, Belldegrun AS, Horvath S, Figlin RA,
Department of Urologic Oncology, Roswell Park Cancer Institute, Buffalo,
New York, USA.